Results 61 to 70 of about 2,533,994 (264)

Sacherschließung unter FRBR und RDA in Theorie und Praxis

open access: yeso-bib. Das offene Bibliotheksjournal, 2016
Zusammenfassung: Der Beitrag untersucht die Rolle der Sacherschließung in den "Functional Requirements for Bibliographic Records" (FRBR) und den damit verwandten Modellen (FRAD, FRSAD, FRBR-LRM) sowie im neuen Katalogisierungsstandard "Resource ...
Heidrun Wiesenmüller
doaj   +1 more source

Biogas purification and enrichment: sustainability metrics analysis of dry anaerobic digester with cashew apple bagasse substrate

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract This study hypothesizes that cashew apple bagasse‐based anaerobic digestion, combined with biochar purification, enhances biogas quality and sustainability. This study aims to investigate the performance and sustainability of a biochar‐based biogas purification technology using cashew apple bagasse as a substrate, with a focus on environmental
Priscila Marchiori   +5 more
wiley   +1 more source

ISBD International Standard Bibliographic Description - Consolidated edition (2011)

open access: yes, 2018
The consolidated edition of the International Standard Bibliographic Description (ISBD) was published by De Gruyter Saur in July 2011. The consolidated edition merges the texts of the seven specialized ISBDs (for books, maps, serials, sound recordings ...
IFLA ISBD Review Group   +1 more
core   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani   +4 more
wiley   +1 more source

Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti   +9 more
wiley   +1 more source

Translational development of crisugabalin for neuropathic pain

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Crisugabalin (HSK16149) is a next‐generation α2δ ligand developed to preserve the mechanistic rationale of gabapentinoids while refining target engagement and exposure‐related tolerability constraints. We performed a translational review of molecular/structural studies, in vivo pharmacology and behavioural safety assessments, phase I clinical ...
Rafael Batista João   +5 more
wiley   +1 more source

Economic evaluations of antiobesity medications: A systematic literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy